CCL2 and neoplasm: LMW– and O–HA also promote expression of pro–inflammatory cytokines such as CCL2, which attract pro–tumorigenic circulating monocytes and stromal cells into the tumor microenvironment [33,123,124], and ECM regulators that support pro–tumor immunogenic and fibrogenic functions [125].